Enalapril Maleate
Brand name: Enalapril Maleate
Rank #445 of 500 drugs by total cost
$17.5M
Total Cost
673,317
Total Claims
$17.5M
Total Cost
23,981
Prescribers
$26
Cost per Claim
79,582
Beneficiaries
1,574,078
30-Day Fills
$729
Avg Cost/Provider
28
Avg Claims/Provider
About Enalapril Maleate
Enalapril Maleate (sold as Enalapril Maleate) was prescribed 673,317 times by 23,981 Medicare Part D providers in 2023, costing the program $17.5M. At $26 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 442 | Istradefylline (Nourianz) | $17.8M | 7,061 |
| 443 | Encorafenib (Braftovi) | $17.6M | 1,209 |
| 444 | Cladribine (Mavenclad) | $17.5M | 228 |
| 445 | Enalapril Maleate (Enalapril Maleate) | $17.5M | 673,317 |
| 446 | Vismodegib (Erivedge) | $17.4M | 1,317 |
| 447 | Anastrozole (Anastrozole) | $17.4M | 626,025 |
| 448 | Naproxen (Naproxen) | $17.4M | 903,928 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology